CUSIP 471871202COM NEWJSPRQ4 2025
24 filings · latest Feb 25, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Velan Capital Investment Management LP | 2.67M | $4.88M |
| 2 | Morgan Stanley | 1.97M | $3.60M |
| 3 | Acorn Capital Advisors, LLC | 1.79M | $3.27M |
| 4 | Goldman Sachs Group Inc | 1.75M | $3.20M |
| 5 | Vanguard Group Inc | 1.33M | $2.43M |
| 6 | Rock Springs Capital Management LP | 1.10M | $2.01M |
| 7 | Millennium Management LLC | 1.07M | $1.97M |
| 8 | Carlyle Group Inc. | 1.07M | $1.94M |
| 9 |
| 4 | Feb 11, 2026 | Morgan Stanley | 13G | 7.0% | 1.97M | SEC |
| 5 | Jan 26, 2026 | Acorn Bioventures, L.P. | 13G/A | 5.3% | 1.49M | SEC |
| 6 | Dec 2, 2025 | Acorn Bioventures, L.P. | 13G | 6.4% | 1.79M | SEC |
| 7 | Nov 14, 2025 | T. Rowe Price Investment Management, Inc. | 13G | 7.1% | 2.06M | SEC |
| 8 | Nov 14, 2025 | Qiming U.S. Healthcare Fund II, L.P. | 13G/A | 3.3% | 929.0K | SEC |
| 9 | Nov 12, 2025 | Kingdon Capital Management, L.L.C. | 13G/A | 4.7% | 1.32M | SEC |
| 10 | Nov 7, 2025 | Morgan Stanley | 13G/A | 2.8% | 784.6K | SEC |
See the full Schedule 13D/13G history for Jasper Therapeutics Inc.
Unlock full history| Woodline Partners LP |
| 1.04M |
| $1.90M |
| 10 | Boothbay Fund Management, LLC | 794.0K | $1.45M |